These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7846115)

  • 1. Inhibitors of the insulin receptor tyrosine kinase.
    Srinivas PR; Grunberger G
    Pharmacol Ther; 1994 Oct; 64(1):23-35. PubMed ID: 7846115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
    Byon JC; Kusari AB; Kusari J
    Mol Cell Biochem; 1998 May; 182(1-2):101-8. PubMed ID: 9609119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.
    Srinivas PR; Wagner AS; Reddy LV; Deutsch DD; Leon MA; Goustin AS; Grunberger G
    Mol Endocrinol; 1993 Nov; 7(11):1445-55. PubMed ID: 7906861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase.
    Cheung AT; Wang J; Ree D; Kolls JK; Bryer-Ash M
    Diabetes; 2000 May; 49(5):810-9. PubMed ID: 10905491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin action in cells expressing truncated or kinase-defective insulin receptors. Dissection of multiple hormone-signaling pathways.
    McClain DA
    Diabetes Care; 1990 Mar; 13(3):302-16. PubMed ID: 2155094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse signaling pathways in the cellular actions of insulin.
    Saltiel AR
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E375-85. PubMed ID: 8638681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Roles of protein-tyrosine phosphatases in insulin-mediated signal transduction system].
    Noguchi T; Matozaki T; Kasuga M
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1200-8. PubMed ID: 9655980
    [No Abstract]   [Full Text] [Related]  

  • 10. Transmembrane signalling by insulin via an insulin receptor mutated at tyrosines 1158, 1162, and 1163.
    Rafaeloff R; Maddux BA; Brunetti A; Sbraccia P; Sung CK; Patel R; Hawley DM; Goldfine ID
    Biochem Biophys Res Commun; 1991 Sep; 179(2):912-8. PubMed ID: 1898412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PI 3-kinase and SH-PTP2 in insulin action.
    Kasuga M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential involvement of FRS2 in insulin signaling.
    Delahaye L; Rocchi S; Van Obberghen E
    Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the actin cytoskeleton in insulin action.
    Tsakiridis T; Tong P; Matthews B; Tsiani E; Bilan PJ; Klip A; Downey GP
    Microsc Res Tech; 1999 Oct; 47(2):79-92. PubMed ID: 10523787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera toxin diminishes tyrosine kinase activity of the insulin receptor.
    Müller-Wieland D; Krone W
    Biochem Int; 1992 Oct; 28(1):161-8. PubMed ID: 1445389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of insulin action and diabetes mellitus].
    Ogawa W; Kasuga M
    Seikagaku; 2003 Oct; 75(10):1332-44. PubMed ID: 14635525
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes: evidence for heterogeneity.
    Caro JF; Jenquin M; Long S
    Mol Cell Biochem; 1992 Feb; 109(2):115-8. PubMed ID: 1625677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
    Sreejayan N; Lin Y; Hassid A
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1086-92. PubMed ID: 12117721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of binding proteins to IRS-1 in insulin signalling.
    Ogawa W; Matozaki T; Kasuga M
    Mol Cell Biochem; 1998 May; 182(1-2):13-22. PubMed ID: 9609110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors.
    Stein EG; Gustafson TA; Hubbard SR
    FEBS Lett; 2001 Mar; 493(2-3):106-11. PubMed ID: 11287005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ; Kahn CR
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.